Shanghai Haixin Group (600851.SH) stated on the investor interaction platform on August 20 that its two pharmaceutical holding companies under the company currently do not produce antiviral traditional Chinese medicine.
海欣股份(600851.SH)：下属两家医药控股公司目前未生产抗病毒类中药
Shanghai Haixin Group (600851.SH): Two pharmaceutical holding companies under it currently do not produce antiviral traditional chinese medicine.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated